These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8853375)

  • 1. cAMP regulation of vasopressin mRNA content in hypothalamo-neurohypophysial explants.
    Sladek CD; Fisher KY; Sidorowicz HE; Mathiasen JR
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R554-60. PubMed ID: 8853375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stimulation of vasopressin gene expression in cultured hypothalamic neurons by cyclic adenosine 3',5'-monophosphate is reversible.
    Sladek CD; Gallagher MJ
    Endocrinology; 1993 Sep; 133(3):1320-30. PubMed ID: 7689952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of extended exposure to hypertonicity on vasopressin messenger ribonucleic acid content in hypothalamo-neurohypophyseal explants.
    Yagil C; Sladek CD
    Endocrinology; 1990 Sep; 127(3):1428-35. PubMed ID: 2387259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
    Wong AO; van der Kraak G; Chang JP
    Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does conversion of ATP to adenosine terminate ATP-stimulated vasopressin release from hypothalamo-neurohypophyseal explants?
    Song Z; Sladek CD
    Brain Res; 2005 Jun; 1047(1):105-11. PubMed ID: 15893296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system.
    Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M
    Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysin expression is stimulated by dopamine D1 agonist in dispersed hypothalamic cultures.
    Mathiasen JR; Larson ER; Ariano MA; Sladek CD
    Am J Physiol; 1996 Feb; 270(2 Pt 2):R404-12. PubMed ID: 8779872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of gonadotrophin-releasing hormone (GnRH), its analogues and melatonin.
    Boczek-Leszczyk E; Stempniak B; Juszczak M
    J Physiol Pharmacol; 2010 Aug; 61(4):459-66. PubMed ID: 20814074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vasopressin secretion from hypothalamic cultures following administration of exogenous vasopressin mRNA.
    Mathiasen JR; Maciejewski-Lenoir D; Bloom FE; Sladek CD
    Exp Neurol; 1996 Oct; 141(2):165-72. PubMed ID: 8812149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of growth-related gene expression and growth inhibition by cyclic adenosine 3',5'-monophosphate-elevating agents in the insulin-producing cell line beta TC1.
    Lavergne C; Breant B; Rosselin G
    Endocrinology; 1992 Nov; 131(5):2351-6. PubMed ID: 1385100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin.
    Roszczyk M; Juszczak M
    Endokrynol Pol; 2014; 65(2):125-31. PubMed ID: 24802736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 receptors mediate dopamine stimulation of immunoreactive atrial natriuretic factor (ANF) release and pro-ANF messenger ribonucleic acid expression of rat hypothalamic neurons in culture.
    Lee D; Huang W; Lim AT
    Endocrinology; 1995 Feb; 136(2):591-7. PubMed ID: 7835293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and oxytocin regulation of cyclic AMP accumulation in rat hypothalamo-neurohypophysial explants in vitro.
    Meeker RB; Michels KM; Hayward JN
    Neurosci Lett; 1990 Jul; 114(2):225-30. PubMed ID: 2168530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic pituitary adrenal axis and hypothalamic-neurohypophyseal responsiveness in water-deprived rats.
    Grinevich V; Ma XM; Verbalis J; Aguilera G
    Exp Neurol; 2001 Oct; 171(2):329-41. PubMed ID: 11573986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin modulates oxytocin mRNA during lactation by its action on the hypothalamo-neurohypophyseal axis.
    Ghosh R; Sladek CD
    Brain Res; 1995 Feb; 672(1-2):24-8. PubMed ID: 7749745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release.
    Gregg CM; Sladek CD
    Neuroendocrinology; 1984 May; 38(5):397-402. PubMed ID: 6728121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitation by forskolin of electrically evoked vasopressin release in vitro requires bursting pattern of stimulation.
    Treiman M; Allesøe K; von Spreckelsen S
    Brain Res; 1989 May; 488(1-2):260-4. PubMed ID: 2545302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotic regulation of vasopressin and oxytocin release is rate sensitive in hypothalamoneurohypophysial explants.
    Yagil C; Sladek CD
    Am J Physiol; 1990 Feb; 258(2 Pt 2):R492-500. PubMed ID: 2309938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin and vasopressin response to hyperosmotic stimulation: in vitro study.
    Ciosek J; Galecka K
    Acta Neurobiol Exp (Wars); 2011; 71(4):496-507. PubMed ID: 22237495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.